| Serial Number | 97336460 |
| Word Mark | ONSURA |
| Filing Date | Tuesday, March 29, 2022 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Wednesday, December 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 1, 2022 |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of alzheimer's disease; pharmaceutical preparations for the prevention and treatment of depression; pharmaceutical preparations for the prevention and treatment of psychological disorders; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of osteoporosis; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; pharmaceutical preparations for the prevention and treatment of aids-related disorders; pharmaceutical preparations that support, encourage and promote bone strength; pharmaceutical preparations that support, encourage and promote bone health; pharmaceutical preparations used in the treatment of bone disorders and bone diseases; pharmaceutical preparations, namely, injectable contraceptives; pharmaceutical preparations, namely, contraceptive preparations; pharmaceutical preparations, namely, fertility enhancement preparations; pharmaceutical preparations, namely, hormone replacement therapy preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations, namely, pharmaceutical agents affecting the central nervous system; pharmaceutical preparations, namely, pharmaceutical agents affecting circulatory systems; pharmaceutical preparations, namely, pharmaceutical agents affecting sensory organs; pharmaceutical preparations, namely, pharmaceutical agents affecting urogenital organs; pharmaceutical preparations, namely, pharmaceutical agents affecting peripheral nervous system |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 4, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Event Date | Event Description |
| Friday, April 1, 2022 | NEW APPLICATION ENTERED |
| Monday, April 4, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 20, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, September 27, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 12, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 1, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 1, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 27, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, June 27, 2023 | SOU EXTENSION 1 FILED |
| Monday, July 31, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, July 31, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Tuesday, August 1, 2023 | TEAS PETITION TO REVIVE RECEIVED |
| Tuesday, August 1, 2023 | PETITION TO REVIVE-GRANTED |
| Tuesday, August 1, 2023 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Wednesday, August 2, 2023 | NOTICE OF REVIVAL - E-MAILED |
| Tuesday, August 29, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, August 29, 2023 | SOU EXTENSION 1 GRANTED |
| Wednesday, August 30, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 21, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, December 21, 2023 | SOU EXTENSION 2 FILED |
| Thursday, December 21, 2023 | SOU EXTENSION 2 GRANTED |
| Saturday, December 23, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 18, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 18, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 18, 2024 | SOU EXTENSION 3 GRANTED |
| Tuesday, June 18, 2024 | SOU EXTENSION 3 FILED |
| Wednesday, December 11, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, December 11, 2024 | SOU EXTENSION 4 FILED |
| Wednesday, December 11, 2024 | SOU EXTENSION 4 GRANTED |
| Wednesday, December 11, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |